跳至主要内容
临床试验/NL-OMON52210
NL-OMON52210已完成不适用

Feasibility of ultrasound particle image velocimetry to quantify flow in the abdominal aorta before and after endovascular aneurysm repair - EchoPIV in AAA trial

Rijnstate Ziekenhuis0 个研究点目标入组 12 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Male or female > 18 years of age
  • - BMI * 30 kg/m2
  • - Infrarenal AAA
  • - Scheduled for elective EVAR
  • - Informed consent form understood and signed, and agrees to all visits

排除标准

  • - Hypersensitivity to the active substance(s) or any of the excipients in
  • - Right-to-left cardiac shunt
  • - Severe pulmonary hypertension (pulmonary artery pressure > 90mmHg)
  • - Uncontrolled systemic hypertension
  • - Severe pulmonary disease (e.g. COPD GOLD 3 or 4, adult respiratory distress
  • - Clinically unstable cardiac disease (recent, < 3 months, or ongoing
  • myocardial infarction, unstable angina at rest, recent percutaneous coronary
  • intervention, clinically worsening cardiac symptoms, severe cardiac
  • arrhythmia*s, endocarditis, etc.)
  • - Prosthetic valves
  • - Loss of renal function (GFR < 31 ml/min), end-stage renal disease
  • - End-stage liver disease
  • - Hypercoagulable status, recent (< 3 months) thrombosis
  • - Congestive heart failure (class III or IV)
  • - Pregnancy
  • - MRI exclusion criteria (pacemakers, cerebral vascular clips, claustrophobia)
  • - Heavily calcified aortoiliac arteries (based on the preoperative CT
  • angiography scan)

研究者

发起方
Rijnstate Ziekenhuis

相似试验